Search

everythinglearnresearchcommunity

for

Search:↓

Human growth hormone treatment improved skin thickness and structure in osteoporosis patients.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The trial aims to understand how obesity and lifestyle affect circadian rhythms in people with schizophrenia and bipolar disorder.

Sleeve gastrectomy leads to significant weight loss and health improvements with few complications.

Changes in SHBG levels don't predict diabetes risk reduction.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

The intensive conventional diet with exercise led to better long-term weight loss and health improvements than the very low calorie diet in obese type 2 diabetics.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Hair loss in older men is linked to higher rates of diabetes and high blood pressure.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Obese women with PCOS are more likely to have fatty liver disease.

Early balding men may have insulin resistance, but lifestyle changes can help.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Children with marasmus have more resting hair follicles and thinner, less pigmented hair, showing long-term malnutrition.